Learn more

HU ZHUOWEI

Overview
  • Total Patents
    15
  • GoodIP Patent Rank
    159,109
  • Filing trend
    ⇩ 75.0%
About

HU ZHUOWEI has a total of 15 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 2012. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are BLAIS NORMAND, IMMUTEP and FOSTER KEITH.

Patent filings in countries

World map showing HU ZHUOWEIs patent filings in countries

Patent filings per year

Chart showing HU ZHUOWEIs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Hu Zhuowei 15
#2 Li Ke 6
#3 Hua Fang 5
#4 Liu Shanshan 3
#5 Lv Xiaoxi 3
#6 Lyu Xiaoxi 2
#7 Zhang Xiaowei 2
#8 Wang Feng 2
#9 Sun Wei 1
#10 Fu Xiaoming 1

Latest patents

Publication Filing date Title
CN110498850A Polypeptide, its derivative and its application in the drug for preparing anti-curing oncoma
CN107629114A Polypeptide, its derivative and its application in the medicine of pulmonary fibrosis resistant is prepared
EP3421484A1 Polypeptide, derivatives thereof, and application thereof in preparation of drugs having resistance to pulmonary fibrosis
CN107056887A A kind of polypeptide and its application in the medicine for treating and preventing tumour is prepared
CN107913273A The application of mesaconine
CN107474115A A kind of polypeptide and its application in the medicine for the treatment of and/or pre- preventing tumor is prepared
WO2015096756A1 Use of polypeptide and derivatives thereof in preparing anti-pulmonary fibrosis drugs
CN104740603A Application of polypeptide in preparation of drugs for treatment and/or prevention of rheumatoid arthritis
CN104740606A Applications of polypeptide in preparation of drugs for treatment or prevention of diabetic cardiomyopathy
CN104740605A Application of polypeptide in preparation of medicines for treating or preventing metabolic syndrome
US2015018382A1 Use of rupatadine in the manufacture of pharmaceutical composition for treating chronic obstructive pulmonary disease